Dissemin is shutting down on January 1st, 2025

Published in

Springer, Journal of Mammary Gland Biology and Neoplasia, 3(15), p. 341-352, 2010

DOI: 10.1007/s10911-010-9193-x

Links

Tools

Export citation

Search in Google Scholar

Role of Lymphatic Vessels in Tumor Immunity: Passive Conduits or Active Participants?

Journal article published in 2010 by Amanda W. Lund ORCID, Melody A. Swartz
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Research in lymphatic biology and cancer immunology may soon intersect as emerging evidence implicates the lymphatics in the progression of chronic inflammation and autoimmunity as well as in tumor metastasis and immune escape. Like the blood vasculature, the lymphatic system comprises a highly dynamic conduit system that regulates fluid homeostasis, antigen transport and immune cell trafficking, which all play important roles in the progression and resolution of inflammation, autoimmune diseases, and cancer. This review presents emerging evidence that lymphatic vessels are active modulators of immunity, perhaps fine-tuning the response to adjust the balance between peripheral tolerance and immunity. This suggests that the tumor-associated lymphatic vessels and draining lymph node may be important in tumor immunity which in turn governs metastasis.